Celebrating a Decade of Collaborative Conversations on Market Access and Reimbursement

10th Anniversary Specials

10 Years
in Review

Join key stakeholders from across Canada’s pharmaceutical and health care sector, reflecting on the polices and initiatives that have shaped the innovation ecosystem and impacted patient access in Canada.

Anniversary
Champagne Toast

Join us for a special prosecco pour, as we raise a glass to 10 years of collaboration, and network with your peers in a post-Day One reception.

Interactive
Sessions

Join smaller-groups discussions on data gaps and how patient experiences and insights can support and solve challenges along the pathways to access.

CONFERENCE CO-CHAIRS
Speaker Name

Andrea Masters

Strategic Access & Pricing Director
Hoffmann-La Roche Limited

Speaker Name

Rebecca Vieira

Head of Access and Pricing
Vertex Pharmaceuticals

Distinguished Faculty
Speaker Name

Gail Attara

President
Gastrointestinal Society

Speaker Name

Tara Cowling

President
Medlior

Speaker Name

Julie Frappier

President & Founder, TOWWERS Program
Data4Actions

Speaker Name

Guillaume Couillard

Executive Director
PMPRB

Speaker Name

Alex Chambers

Senior Market Access Manager
Bayer Inc.

Speaker Name

Mina Tadrous

Assistant Professor, Leslie Dan Faculty of Pharmacy
University of Toronto

Featuring Key Topics

Pharmaceutical Policy Power Panel: Hear reflections and projections on the evolution of Canada’s pharmaceutical access environment so that you can plan for 2025 and beyond

Technology Use Cases for Pharma: Examine practical applications for managing market access and drug negotiations

Hypothetical Case Study and Breakout Discussion: Identify opportunities to improve the drug to market process through patient inclusivity

Working Group on how to advance the use of value-based agreements in Canada

About the conference

The Canadian pharmaceutical market is undergoing significant transformation. CADTH has evolved into Canada’s Drug Agency (CDA), the pCPA has transitioned into a standalone entity, and federal policies are advancing with funding for drugs for rare diseases and progress on the pharmacare file. Meanwhile, the PMPRB has resumed consultations on final guidelines for drug pricing reviews, adding further complexity to an already dynamic landscape.

CI’s Forum on Pathways to Access & Reimbursement provides a critical platform for stakeholders—government, pharmaceutical manufacturers, patients, and payers—to engage in meaningful discussions on market access, drug price regulation and drug reimbursement. This is your opportunity to explore innovative approaches to ensure patient access to the right drug at the right time.

As in years prior, the 2025 program is curated to ensure that you start the new year with a clear view of Canada’s pharmaceutical landscape. It will put a strong focus on evidence generation, value-based decision-making, expedited pathways to access, and patient perspectives.

Why Attend

iconBUILD a market access and drug pricing plan based on insights from CDA, INESSS, patients, and industry leaders

iconPREPARE for PMPRB’s impending draft guidelines for drug pricing review

icon ALIGN drugs submissions with payer priorities

iconDEVELOP an understanding of how to use AI and digital tools to support market access

iconCOLLABORATE with the life sciences community on strategies to improve the collection and use of RWE for drug access decisions

WHO YOU WILL MEET

Practitioners at every level with experience in:

  • Pricing
  • Reimbursement
  • Market access
  • Patient access
  • Government and regulatory affairs
  • Health economics
  • Research and development
  • Policy and compliance
  • Pharmacy services
  • Marketing
  • National trade
  • Formularies
  • Business development
  • Sales

From brand generic and manufacturing companies involved in:

  • Product development
  • Public drug programs
  • Pharmaceutical benefits
  • Pharmaceutical strategy
  • Drug submissions
  • Formulary management
  • Policy and economic analysis
  • Provider services and
  • relations
  • Pharmacy

And representatives from:

  • Associations
  • Patient Advocacy Groups
Testimonials
Quote Icon

Great overview, gave me a different perspective. Got me thinking differently.

Team Lead, Pricing and Contracts, GSK
Quote Icon

I liked the quality of the speakers.

Manager, Market Access and HTA, BMS
Quote Icon

Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.

Manager, Pricing and Contracts, Astellas:
Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image